Search Results - "Ly, Bevan H."

Malignant mesothelioma: Facts, Myths, and Hypotheses by Carbone, Michele, Ly, Bevan H., Dodson, Ronald F., Pagano, Ian, Morris, Paul T., Dogan, Umran A., Gazdar, Adi F., Pass, Harvey I., Yang, Haining

“…Malignant mesothelioma (MM) is a neoplasm arising from mesothelial cells lining the pleural, peritoneal, and pericardial cavities. Over 20 million people in…”
Get full text

18F-choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer by Kwee, Sandi A., Coel, Marc N., Ly, Bevan H., Lim, John

“…Purpose Apply measurability criteria based on the response evaluation criteria in solid tumors (RECIST) to lesions found on 18 F-choline positron emission…”
Get full text

(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer by Kwee, Sandi A, Coel, Marc N, Ly, Bevan H, Lim, John

“…Apply measurability criteria based on the response evaluation criteria in solid tumors (RECIST) to lesions found on (18)F-choline positron emission tomography…”
Get full text

Loco-regional treatment in metastatic breast cancer patients: Is there a survival benefit by Ly, Bevan H, Nguyen, Nam P, Vinh-Hung, Vincent, Rapiti, Elisabetta, Vlastos, Georges

“…A number of studies have recently demonstrated a survival benefit in stage IV breast cancer patients following surgical resection of the primary tumor. Here,…”
Get full text

Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth by Nasu, Masaki, Carbone, Michele, Gaudino, Giovanni, Ly, Bevan H, Bertino, Pietro, Shimizu, David, Morris, Paul, Pass, Harvey I, Yang, Haining

“…The ribonuclease ranpirnase (Onconase) has been used empirically to treat malignant mesothelioma (MM) patients, and some of them had prolonged survivals. The…”
Get full text